Skip to main content

Nerve Repair and Regeneration Market Size Worth USD 14.21 Billion in 2032 | Emergen Research

Rising prevalence of neurological disorders is a key factor driving nerve repair & regeneration market revenue growth

Vancouver, Nov. 15, 2023 (GLOBE NEWSWIRE) — The global Nerve Repair and Regeneration Market will be worth USD 14.21 Billion by 2032, according to a current analysis by Emergen Research. The growth of this market can be attributed to the increasing government support for the research and development of neurological disorders. Technological advancements of the healthcare infrastructure in the emerging economies are expected to drive the growth of the Nerve Repair and Regeneration market over the forecast period. The availability of favorable health insurance coverage for treating neurological disorders is a key contributing factor to the growing demand for the products. 

Stringent government regulations on product approval might be a restraining factor to the growth of the market. Moreover, the high costs associated with the products and the presence of alternative drug therapies might hamper the demand for the product over the forecast period.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/385

Report DetailsOutcome
Market size value in 2019USD 6.05 Billion
CAGR (2023 – 2032)9.0%
Revenue forecast in 2032USD 14.21 Billion
Base year for estimation2022
Historical data2019-2021
Forecast period2023-2032
Quantitative unitsVolume in Tons, Revenue in USD Thousand, and CAGR from 2023 to 2032
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments coveredProduct, Surgery, region
Regional scopeNorth America; Europe; Asia Pacific; Central & South America; MEA
Country scopeU.S.; Canada; Mexico; U.K.; Germany; France; Italy; Spain; China; India; Japan; South Korea; Brazil; Saudi Arabia; South Africa; Turkey
Key companies profiledAbbott Laboratories, Medtronic, Plc, Boston Scientific Corporation, BAXTER INTERNATIONAL, INC., LIVANOVA, PLC., AXOGEN, INC., Stryker Corporation, Cyberonics, Inc., INTEGRA LIFESCIENCES, and SOTERIX MEDICAL, INC.
Customization scope10 hrs of free customization and expert consultation

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/385

Major Companies and Competitive Landscape
The Nerve Repair and Regeneration Market is moderately fragmented with a large number of small and medium-sized manufacturers, which account for a major part of the global share. The manufacturers are well-equipped with manufacturing facilities and are involved in several research & development activities. Some of the prominent players in the Nerve Repair and Regeneration Market include:

  • Abbott laboratories
  • Medtronic, Plc
  • Boston Scientific Corporation
  • BAXTER INTERNATIONAL, INC.
  • LIVANOVA, PLC.
  • AXOGEN, INC.
  • Stryker Corporation
  • Cyberonics, Inc.
  • INTEGRA LIFESCIENCES
  • SOTERIX MEDICAL, INC.

Strategic Development

In Jan 2023, Stimgenics, LLC, was acquired by Medtronic plc. Stimgenics is a privately held company which is based in Bloomington, Illinois. The company has pioneered a novel spinal cord stimulation (SCS) waveform known as Differential Target Multiplexed (DTM™) Spinal Cord Stimulation. The therapy is delivered via Medtronic Intellis™ platform and is expected to help the patients suffering from chronic pain.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/385

Some Key Highlights from the Report

  • In September 2019, U.S. Food and Drug Administration (FDA) approved Abbott’s Proclaim XR™ recharge-free neurostimulation platform for people living with chronic pain. The approval helped Abbott to secure a higher market share and increase its neurostimulation devices product portfolio.
  •  The Neurostimulation and Neuromodulation Surgeries segment held the largest market share of 34.4% in 2019. The technological advancements of the products to increase the efficiency of the treatments and reduce chronic pain are expected to drive the growth of the Neurostimulation and Neuromodulation Surgeries.
  • The Biomaterial segment is forecasted to grow with the fastest CAGR of 9.6% over the forecast period. The technological advancements for nerve repair and regeneration and the increasing investments by the major market players to increase the efficiency of the treatment for neurological disorders are expected to drive biomaterial products.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@  https://www.emergenresearch.com/industry-report/nerve-repair-and-regeneration-market

Emergen Research has segmented the global Nerve Repair and Regeneration Market on the basis of Product, Surgery, and region:

  • Product Outlook (Revenue, USD Billion; 2019-2032)
    • Neurostimulation and Neuromodulation Devices (Sacral Nerve, Spinal Cord, Vagus Nerve, Gastric Electric, and Deep Brain Stimulation Devices)
    • Biomaterial
  • Surgery Outlook (Revenue, USD Billion; 2019-2032)
    • Stem Cell Therapy
    • Direct Nerve Repair
    • Nerve Grafting
    • Neurostimulation and Neuromodulation Surgeries
  • Regional Outlook (Revenue, USD Billion; 2019-2032)
    • North America
      1. U.S.
      2. Canada
    • Europe
      1. Germany
      2. UK
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • MEA
      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

Curated Reports You Shouldn’t Miss: Dive In Now!

Medical Image Analytics Market By Modality (Tomography, Ultrasound Imaging, Radiographic Imaging, Combined Modalities), By Imaging Type (2D, 3D, 4D Imaging), By Application (Orthopedic, Dental, Neurology, Cardiology, Oncology, Obstetrics & Gynecology) and By Regions Forecasts to 2027

Operating Room Integration Systems Market By Device Type (Audio Video Management System, Display System, Documentation Management System), By End-Use, By Application (General Surgery, Orthopedic Surgery, Neurosurgery), Forecasts to 2027

Precision Medicine Market By Technology (Big-Data Analytics and Bioinformatics), By Application (Oncology and CNS), By End-Use (Pharmaceutical Companies and Healthcare IT Companies), and By Region Forecast to 2030

Microfluidics Market, By Material Type (Polymer, Silicon, Glass, Others), By Application (Point-of-Care Testing, Drug Delivery Systems, Others), By Components (Microfluidic Chips, Micropumps, Microneedles, Others), and By Region Forecast to 2030

Femtech Market By Type (Devices, Software, Services), By End-Use (Direct-to-Consumer, Hospitals, Fertility Clinics, Surgical Centers, Diagnostic Centers), By Application (Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Healthcare), By Region, Forecasts to 2027

 About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Japanese Version: Nerve Repair and Regeneration Market

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-nerve-repair-and-regeneration-market

19

2019

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.